|
Research and Development
Future Perspectives
Future Plans
- Establish specialized drug manufacturing platforms.
- Enhance R&D and marketing capability through strategic alliances with international companies in Asia.
- Focus marketing efforts on core disease categories, strengthen distribution competitiveness, and become the best clinical and distribution competitive strategic partner for innovative international biotechnology companies in the Chinese market.
- Enhance the distribution channels in Taiwan and China to integrate the R&D and marketing capability for special Chinese diseases.
- International approaches: assertively seek new uprising countries in Europe、America、Japan、South-east Asia, and Mid/South America as collaboration partners to market the local market together.
Cooperation Plans
- Improve technology
- Dedicate goals to early-stage development of new drugs
- Invest in or establish new biotechnology companies
- Form strategic alliances
- Form alliances with international or local companies to develop brand new drugs
Development-oriented plans
TTY Biopharm is trying to become an international biotech pharmaceutical factory with the strategies of “R&D marketing and marketing R&D.” We invest 12.6% of the yearly revenue in the R&D and demonstrate our professional R&D capability with the development of cancer medications and special formulations as the core. We will put more professionals in the development of core technologies and focus on main products and their marketing in the primary market. In addition, we hope to establish an excellent R&D value chain of drugs and form strategic alliances with international biotechnology companies so as to become an enterprise with outstanding competitiveness in the new century.
Short-term: apply core technology; such as sustained release and liposome technologies to develop new drug delivery systems and target-aiming remedies.
Mid-term: Build upon technical and knowledge platforms, to research and develop medications for prevalent Chinese diseases and engage in the study of utilizing existing compositions to develop new indications to obtain patented new drugs.
Long term: participate in global new drug’s early-stage R&D projects of innovative biotechnology companies, to share the results of new drug’s global patents.
|
